📰 Digital Pharma News
Page 2 - Digital Pharma News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Digital Pharma. Real-time updates on events, politics, business and more.
March 11, 2021
AstraZeneca’s coronavirus vaccine is facing a wave of mistrust in Europe—a striking difference from its stellar reputation in the U.K. While 81% of Britons believe the AZ vaccine is safe, which is on par with similar 79% of U.K. citizens who trust of the Pfizer vaccine, only 43% of Germans and 33% of French citizens consider it safe, accoriding to a surveyed by YouGov.
March 11, 2021
AstraZeneca’s COVID-19 vaccine rollout has gotten off to a rocky start in Europe. First, a supply shortfall triggered a public back-and-forth between executives and government officials. Then, several countries raised efficacy doubts for people over 65. Now some countries are raising safety concerns.
March 10, 2021
Mar 10, 2021 10:24am Johnson & Johnson will sell another 100 million COVID-19 vaccine doses to the U.S., according to reports.(J&J) One year ago this week, the COVID-19 pandemic hit home with Americans when Tom Hanks revealed he had tested positive and the NBA postponed its season indefinitely. Things have changed mightily since then: A national vaccine rollout is gaining steam, and the U.S. is inking yet another huge supply deal. The Biden administration is purchasing another 100 million d...
March 10, 2021
Mar 10, 2021 9:35am PatientPoint and Outcome Health are merging to form the new PatientPoint point-of-care network and company. (Alpha Stock Image) After enduring a turbulent few years, point-of-care advertising and marketing company Outcome Health is getting a makeover, thanks to a merger. PatientPoint is merging with Outcome to create PatientPoint Health Technologies point-of-care network, and in the process its retiring the Outcome name. The combined company will be led by PatientPoint ex...
March 9, 2021
Patrick Soon-Shiong, M.D., executive chairman of ImmunityBio and NantKwest (NantKwest) ImmunityBio and NantKwest have begun dosing participants with subcutaneous, sublingual and oral COVID-19 vaccine candidates. The trials are designed to determine which combination of routes of administration holds the most potential. While a clutch of COVID-19 vaccines are now in commercial use around the world, the potential for the coronavirus to become a pathogen that continues to circulate for years means...
March 9, 2021
Mar 9, 2021 10:30am Johnson & Johnson is one of several companies working around the clock to scale up vaccine supply. (Kunal Mahto/iStock/Getty Images Plus/Getty Images) Johnson & Johnson execs have assured investors and officials that the company is "comfortable" hitting its vaccine delivery targets. But with its U.S. rollout underway, the pharma giant has run into some supply problems in Europe, Reuters reports. J&J’s shot isn’t yet authorized in Europe, but the company has been gear...
March 9, 2021
Mar 9, 2021 12:12pm Eiger BioPharmaceuticals Zokinvy, recently approved by the FDA for ultrarare rapid-aging diseases that affect an estimated 600 children worldwide, is the most expensive drug in U.S. pharmacies in 2021, according to GoodRx.(Jacoblund) Eiger BioPharmaceuticals in November snagged FDA clearance for Zokinvy for ultra-rare rapid-aging diseases that affect an estimated 600 people worldwide. Orphan drugs that treat small patient populations typically come with high prices, but Zoki...
March 8, 2021
Mar 8, 2021 10:23am Theres a ready market for viral vectors. Matica, a new CDMO and a subsidiary of South Korea-based CHA Biotech, will soon be poised to help meet the demand. (Harvard University) A lack of global capacity to produce cell and gene therapies has been exacerbated by an even more pressing need: to develop and manufacture coronavirus vaccines. So it appears the timing is right for Matica Biotechnology, a developer and producer of viral vectors, to put down roots in the United State...
February 20, 2021
North Bucks (100% remote) | £35k - £45k | NP747 Are you stuck in a rut and looking for that next opportunity, an exciting one with an agency that are really pushing the boundaries? If so, then look no further. Back in 2011 this agency began working with a whole host of clients, producing cutting-edge digital work and have gone from strength to strength. Over the last 10 years theyve picked up some global pharma clients enabling them to set up and launch their medcomms team recently. Currentl...
January 22, 2021
North Bucks (100% remote) | £40k - £60k | NP747 Are you stuck in a rut and looking for that next opportunity, an exciting one with an agency that are really pushing the boundaries? If so, then look no further. Back in 2011 this agency began working with a whole host of clients, producing cutting-edge digital work and have gone from strength to strength. Over the last 10 years theyve picked up some global pharma clients enabling them to set up and launch their medcomms team. Currently this tea...